Melatonin Zentiva 2 mg, Retardtabletten

7680688410020 CH-68841 Tabletten

No image available

Article details

Package size
1 x 98
Selling units
98
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/06/2026
Patient information leaflet
Français
17/06/2026
Patient information leaflet
Italien
17/06/2026
Summary of Product Characteristics
Allemand
17/06/2026
Summary of Product Characteristics
Français
17/06/2026
Summary of Product Characteristics
Italien
17/06/2026

Detailed composition

Substance Quantity Type Category
melatoninum
2.0 MG Substance Wirkstoff (Principe actif)
calcii hydrogenophosphas dihydricus
- Substance HNIDK
lactosum monohydricum
85.0 MG Substance HBESI
ammonio methacrylatis copolymerum B
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
talcum
- Substance HNIDK
magnesii stearas
- Substance HNIDK

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
68841
Drug name
Melatonin Zentiva, Retardtabletten
Galenic form
RETT
ATC Code
N05CH01
Authorization status
Z
Dispensing category
B
First authorization
17/08/2023
Authorization expiration date
16/08/2028
IT Number
01.03.1.
Domain
Human medicine
Field of application
Primäre Insomnie

Package details

Description (FR)
MELATONIN Zentiva cpr ret 2 mg 1x98 pce
Description (DE)
MELATONIN Zentiva Ret Tabl 2 mg 1x98 Stk
Market launch
01/04/2026
Narcotic (BTM)
No

Other package sizes (1)

MELATONIN Zentiva cpr ret 2 mg 21 pce
1 x 21 TABL
GTIN: 7680688410013
View
Buy us a coffee Explore the data